Navigation Links
Home visiting program for first-time moms may be struggling to reduce serious injuries to children
Date:12/12/2012

New research from PolicyLab at The Children's Hospital of Philadelphia shows that one of the nation's largest programs providing home visitation support for at-risk mothers and children may not be as successful in reducing early childhood injuries as it was in earlier evaluations. The researchers evaluated the Nurse-Family Partnership (NFP) over seven years of widespread implementation in Pennsylvania and found that children served by the program had no fewer injuries than children in comparable families not enrolled in the programand in some less serious cases, had higher injury rates. The results of the study are published in the current issue of Maternal Child Health Journal.

"A lot of evidence for the home visitation program had shown positive outcomes for mothers and children within the targeted geographic areas of randomized clinical trials," said David Rubin, MD, MSCE, co-director of PolicyLab and one of the study's authors. "Our research has previously reported on continued effectiveness for some of these outcomes as the service area grew larger, such as reducing rapid-succession second pregnancies and smoking among mothers. However, regrettably, this study failed to demonstrate the program's previous success in preventing child injuries."

The current peer-reviewed evaluation found that nearly one-third of the families served by NFP in Pennsylvania had emergency room visits for injuries to children from birth through the second birthday, a rate 12% greater than for families not enrolled in the program.

"We should not be surprised that there have been some bumps in the road as we increase the scale of home visiting programs. This research highlights the need to continue evaluating these programs after they have been implemented in communities," said the study's lead researcher Meredith Matone, MHS." Evaluation should focus on identifying local barriers that may be undermining a program's success. By identifying these b
'/>"/>

Contact: Dana Mortensen
mortensen@email.chop.edu
267-426-6092
Children's Hospital of Philadelphia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
2. Ivy Neurological Sciences Internship program funded at TGen
3. Brief training program improves resident physicians empathy with patients
4. Southeast program to fight diabetes awarded nearly $10 million by HHS
5. Program to coordinate regional systems to speed heart attack care
6. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
7. UC San Diego Superfund Research Program receives $15 million grant renewal
8. UCLA launches first face transplantation program in western US
9. Rutgers leads effort to replicate care management programs in 4 U.S. cities
10. Steffi Nossen School of Dance Gears Up for Summer with Exciting Programming for All Ages
11. Coronary rehabilitation programs in Europe are underused
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nike Swim ... and staff whose mission is to stimulate a love ... “Nike Swim Camps provide campers the opportunity to train ... nation,” says Paul Merrion, Vice President of US Sports ... enabling each swimmer to build confidence and improve their ...
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine ... products, is hosting the Nitrosigine Pump Challenge at the ... at The Arnold Sports Festival in Columbus, Ohio. The ... 8, 2015. , Nitrosigine is a patented ingredient ... notification status; now affirmed as GRAS.^ It has been ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3
... and Accelerates Physician TrainingGREAT BARRINGTON, Mass., March 17 ... surgical training models, is improving how ENT physicians ... Trainer. This innovative technology was recently designed ... on their new FinESS(TM) Sinus Treatment, a less-invasive ...
... 17 Innophos Holdings, Inc. (Nasdaq: ... declared a dividend of $0.17 per share of common stock. ... stockholders of record as of the close of business on ... , Innophos Holdings, Inc., the parent company of Innophos, Inc. ...
... the past few years, a number of anti-cancer drugs ... key molecules of tumor cells. Among these is an ... that is found in large amounts on the surface ... molecule, called epidermal growth factor receptor, or EGF-R for ...
... for Drug Evaluation and Research (CDER), industry, and academia will convene ... (April 26-29; Arlington, VA) to discuss statistical methodologies and quantitative ... , ... Horsham, PA (Vocus) March 17, 2009 -- ...
... John Hancock Life Insurance Company led the industry ... to recent industry year-end surveys of LTC insurers.* In ... across all of its LTC insurance businesses, giving the ... marks John Hancock,s second year in a row as ...
... What can you buy with a dollar anymore? ... and treatment for those who cannot afford to battle breast ... Brandon Mendelson and the 1 in 8 Foundation are challenging ... $1 and provide care and complete support for women and ...
Cached Medicine News:Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 2Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 3Health News:Innophos Holdings, Inc. Declares Quarterly Dividend 2Health News:Lung cancer: Molecular scissors determine therapy effectiveness 2Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 3Health News:$1 Can Make The Difference 2
(Date:3/4/2015)... AUSTIN, Texas , March 4, 2015 /PRNewswire/ ... Phase II pilot study in patients with moderate ... JAMA Dermatology. The open-label Phase II trial evaluated ... Human™ monoclonal antibody that targets interleukin-1 alpha (IL-1a). ... and inflammatory cells present in skin lesions. The ...
(Date:3/4/2015)... , March 4, 2015 UPM Pharmaceuticals, a ... agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg ... to be the first drug approved to treat hypoactive ... female sexual dysfunction. The tablets will be ... Bristol, Tennessee . Dr. ...
(Date:3/4/2015)... March 4, 2015   Mayo Clinic and ... develop the next generation of wearable biosensors designed to ... that this technology will be game-changer. These patch biosensors ... James Levine, M.D., Ph.D. , a Mayo Clinic ... inexpensive, and can be integrated into the care people ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
Medicine Products: